{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:56:26Z","timestamp":1792659386076,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,9,1]],"date-time":"1985-09-01T00:00:00Z","timestamp":494380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1985,9,1]],"date-time":"1985-09-01T00:00:00Z","timestamp":494380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1985,9]]},"DOI":"10.1007\/bf00179439","type":"journal-article","created":{"date-parts":[[2004,8,22]],"date-time":"2004-08-22T05:07:21Z","timestamp":1093151241000},"page":"315-318","source":"Crossref","is-referenced-by-count":22,"title":["Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report"],"prefix":"10.1007","volume":"3","author":[{"given":"Werner","family":"Scheithauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Maida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF00179439_CR1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/bmj.2.5658.662","volume":"2","author":"RM Hardisty","year":"1969","unstructured":"Hardisty RM, McElwain TJ, Darby CW: Vincristine and prednisone for the induction of remissions in acute childhood leukemia. Br Med J 2:662\u2013665, 1969","journal-title":"Br Med J"},{"key":"BF00179439_CR2","first-page":"62","volume":"183","author":"A Panoff","year":"1971","unstructured":"Panoff A: Pathogenesis of epileptiform seizures in acute leucosis in childhood. Arch Kinderheilkd 183:62\u201368, 1971","journal-title":"Arch Kinderheilkd"},{"key":"BF00179439_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0022-510X(70)90013-4","volume":"10","author":"WG Bradley","year":"1970","unstructured":"Bradley WG, Lassman L, Pearce GW, Walton JN: The neuropathy of vincristine in man: clinical, electrophysiological and pathological studies. J Neurol Sci 10:107\u2013131, 1970","journal-title":"J Neurol Sci"},{"key":"BF00179439_CR4","first-page":"1258","volume":"33","author":"JF Holland","year":"1973","unstructured":"Holland JF, Scharlau C, Gailani S, Krant MJ, Olson KB, Horton J, Shnider BI, Lynch JJ, Owens A, Carbone PP, Colsky J, Grob D, Miller SP, Hall TC: Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res 33:1258\u20131264, 1973","journal-title":"Cancer Res"},{"key":"BF00179439_CR5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJM197407182910305","volume":"18","author":"HD Weiss","year":"1974","unstructured":"Weiss HD, Walker MD, Wiernik PH: Neurotoxicity of commonly used antineoplastic agents. N Engl J Med 18:127\u2013133, 1974","journal-title":"N Engl J Med"},{"key":"BF00179439_CR6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3476(73)80602-X","volume":"82","author":"FL Johnson","year":"1973","unstructured":"Johnson FL, Bernstein ID, Hartmann JR, Chard RL Jr: Seizures associated with vincristine sulfate therapy. J Pediatr 82:699\u2013702, 1973","journal-title":"J Pediatr"},{"key":"BF00179439_CR7","first-page":"455","volume":"188","author":"OA J\u00fcrgenssen","year":"1976","unstructured":"J\u00fcrgenssen OA, Pichler E: Zerebell\u00e4re Vincristin-Toxizit\u00e4t. Klin P\u00e4diatr 188:455\u2013458, 1976","journal-title":"Klin P\u00e4diatr"},{"key":"BF00179439_CR8","first-page":"517","volume":"287","author":"BA Mubashir","year":"1972","unstructured":"Mubashir BA, Bart JB: Vincristine neurotoxicity. N Engl J Med 287:517, 1972","journal-title":"N Engl J Med"},{"key":"BF00179439_CR9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/030089168407000307","volume":"70","author":"F Dallera","year":"1984","unstructured":"Dallera F, Gamoletti R, Costa P: Unilateral seizures following vincristine intravenous injection. Tumori 70:243\u2013244, 1984","journal-title":"Tumori"},{"key":"BF00179439_CR10","first-page":"329","volume":"1","author":"H Ludwig","year":"1981","unstructured":"Ludwig H, Fritz E: Individualized chemotherapy in multiple myeloma by cytostatic drug sensitivity testing of colony-forming stem cells. Anticancer Res 1:329\u2013334, 1981","journal-title":"Anticancer Res"},{"key":"BF00179439_CR11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198405243102104","volume":"310","author":"B Barlogie","year":"1984","unstructured":"Barlogie B, Smith L, Alexanian R: Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med 310:1353\u20131356, 1984","journal-title":"N Engl J Med"},{"key":"BF00179439_CR12","first-page":"44","volume-title":"Liquorproteinprofile bei entz\u00fcndlichen Erkran-kungen des Nervensystems","author":"EM Maida","year":"1984","unstructured":"Maida EM: Liquorproteinprofile bei entz\u00fcndlichen Erkran-kungen des Nervensystems. W. Maudrich, Wien-M\u00fcnchenBern, 1984, p 44"},{"key":"BF00179439_CR13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1097-0142(196901)23:1<122::AID-CNCR2820230114>3.0.CO;2-E","volume":"23","author":"M Slater","year":"1969","unstructured":"Slater M, Wainer RA, Serpick AA: Vincristine neurotoxicity with hyponatremia. Cancer 23:122\u2013125, 1969","journal-title":"Cancer"},{"key":"BF00179439_CR14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archinte.1973.03650110061013","volume":"132","author":"GL Robertson","year":"1973","unstructured":"Robertson GL, Bhoopalam N, Zelkowitz LJ: Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone. Arch Intern Med 132:717\u2013720, 1973","journal-title":"Arch Intern Med"},{"key":"BF00179439_CR15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/archpedi.1966.02090120124015","volume":"112","author":"RN Fine","year":"1966","unstructured":"Fine RN, Clarke RR, Shore NA: Hyponatremia and vincristine therapy. Am J Dis Child 112:256\u2013259, 1966","journal-title":"Am J Dis Child"},{"key":"BF00179439_CR16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-3476(72)80381-0","volume":"81","author":"RM Suskind","year":"1972","unstructured":"Suskind RM, Brusilow SW, Zehr J: Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level). J Pediatr 81:90\u201392, 1972","journal-title":"J Pediatr"},{"key":"BF00179439_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archneur.1969.00480080099012","volume":"20","author":"ML Shelanski","year":"1969","unstructured":"Shelanski ML, Wisniewski H: Neurofibrillary degeneration induced by vincristine therapy. Arch Neurol 20:199\u2013206, 1969","journal-title":"Arch Neurol"},{"key":"BF00179439_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jnci\/37.3.331","volume":"37","author":"JA Burdman","year":"1966","unstructured":"Burdman JA: A note on the selective toxicity of vincristine sulfate on chickembryo sensory ganglia in tissue culture. J Natl Cancer Inst 37:331\u2013335, 1966","journal-title":"J Natl Cancer Inst"},{"key":"BF00179439_CR19","first-page":"2474","volume":"67","author":"HE Finkel","year":"1967","unstructured":"Finkel HE: Vincristine therapy. NY J Med 67:2474\u20132478, 1967","journal-title":"NY J Med"},{"key":"BF00179439_CR20","first-page":"1369","volume":"286","author":"PL Weiden","year":"1972","unstructured":"Weiden PL, Wright SE: Vincristine neurotoxicity. N Engl J Med 286:1369\u20131370, 1972","journal-title":"N Engl J Med"},{"key":"BF00179439_CR21","first-page":"486","volume":"71","author":"J Hildebrand","year":"1971","unstructured":"Hildebrand J, Kenis Y: Additive toxicity of vincristine and other drugs for the peripheral nervous system. Acta Neurol Bel 71:486\u2013491, 1971","journal-title":"Acta Neurol Bel"},{"key":"BF00179439_CR22","first-page":"1015","volume":"42","author":"B Jones","year":"1973","unstructured":"Jones B, Holland JF: Optimal use of asparaginase in acute lymphocytic leukemia of childhood. (Abstract). Blood 42:1015, 1973","journal-title":"Blood"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00179439.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00179439\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00179439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00179439.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:56:15Z","timestamp":1678557375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00179439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["BF00179439"],"URL":"https:\/\/doi.org\/10.1007\/bf00179439","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}